2009
DOI: 10.1016/j.avsg.2008.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous Zenith Endografting for Abdominal Aortic Aneurysms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(14 citation statements)
references
References 19 publications
0
14
0
Order By: Relevance
“…In more recent series, the mean LOS has been reported to be between 1.4 to 3.1 days. 26,27 We report the shortest mean LOS for PEVAR with 1.0 6 1.1 days.…”
Section: Discussionmentioning
confidence: 84%
“…In more recent series, the mean LOS has been reported to be between 1.4 to 3.1 days. 26,27 We report the shortest mean LOS for PEVAR with 1.0 6 1.1 days.…”
Section: Discussionmentioning
confidence: 84%
“…The two types of SMCD that were used in the reviewed studies were Prostar XL and the Proglide system. Prostar XL was used in 27 studies, 16,17,[20][21][22][23][24][25][26][27][29][30][31][32][33][34][35][36][37][38][39][40][41][43][44][45][46] and Proglide was used in 6 studies. 18,20,[27][28][29]42 In three studies, 20,27,29 both Prostar and Proglide devices were used.…”
Section: Results Of Smcdmentioning
confidence: 99%
“…18,20,[27][28][29]42 In three studies, 20,27,29 both Prostar and Proglide devices were used. The rates of technical success by access site ranged between 63 and 100%, but with only two articles 34,37 reporting rates below 80% and most articles [16][17][18][20][21][22][23][24][25][26][27][28][29][30][31][32][33]35,36,[38][39][40][41][42][43][44][45][46] reporting rates between 89 and 100%. The rates of technical success by patient ranged between 53 and 100%, but with only three articles reporting rates below 80% 22,34,35 and most articles reporting rates between 89 and 100%.…”
Section: Results Of Smcdmentioning
confidence: 99%
“…21 Our technical success rate of 95% compares favorably with prior reports (Table III). [1][2][3][4][5][6][7][8][9][10][11][12]14,20,[22][23][24][25][26][27][28][29][30][31][32][33][34][35][36] Despite the use of different devices and some variations on techniques, three meta-analysis have shown >90% technical success with a low incidence of complications. 13,37,38 With respect to reports dealing with thoracic or fenestrated and branched endografts, there are limited data.…”
Section: Discussionmentioning
confidence: 97%